Blue Jet Healthcare Limited

Key facts Founded: 1968 (originally as Jet Chemicals Pvt Ltd) Sector: Specialty pharmaceutical and healthcare ingredients/intermediates Specialties: Contrast media intermediates, high-intensity sweeteners (saccharin & salts), advanced intermediates & APIs Notable first: India’s first manufacturer of saccharin and its salts Listing: Publicly listed in India (NSE: BLUEJET, BSE: 544009) Business focus and model Blue Jet runs a CDMO-driven model, collaborating with global pharma innovators and large generics players to develop and manufacture advanced intermediates and selected APIs. The company emphasizes specialized chemistry capabilities, long-term contracts, and high entry-barrier products rather than a broad formulations portfolio. Its business is primarily organized into three product categories: Contrast media intermediates – key building blocks used in diagnostic imaging agents. High-intensity sweeteners – especially saccharin and its salts, supplied to pharma, food, beverage, and animal-feed industries. Pharma intermediates & APIs – niche intermediates and selected APIs for regulated markets. Capabilities and manufacturing The company highlights backward integration, particularly in saccharin, including indigenous sourcing of key raw materials and significant installed capacity for saccharin sodium production (around 3,000 MT per year). Blue Jet’s manufacturing footprint and R&D capabilities are geared to handle multi-step complex chemistry, regulatory requirements of regulated markets, and long-term CDMO relationships. Its specialization in contrast media intermediates and sweeteners positions it as a niche, high-value ingredient supplier rather than a broad-based formulations company.